ACIST enters StatSensor Creatinine Meter distributing agreement

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

ACIST Medical Systems, a Bracco Group company, has signed a distribution agreement with Nova Biomedical to distribute the StatSensor Creatinine Meter.

Under the agreement, ACIST and the Waltham, Mass.-based Nova will co-exclusively market and distribute the StatSensor Creatinine Meter for radiology and cardiology within North America initially, the two companies said.

The Eden Prairie, Minn.-based ACIST said it will continue to support customers who have previously purchased the StatSensor Creatinine Meter under the E-Z-Chem brand name from E-Z-EM, prior to its acquisition of E-Z-EM.

The StatSensor Creatinine device quickly measures a patients blood creatinine level and calculates their estimated glomerular filtration rate prior to contrast agent administration via a finger prick, allowing the clinician to assess patient renal function and eligibility for IV contrast administration thereby minimizing the potential for contrast-induced nephropathy, ACIST said.